288 related articles for article (PubMed ID: 8661353)
1. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
3. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
6. Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion.
Paul WE; Mizuguchi J; Brown M; Nakanishi K; Hornbeck P; Rabin E; Ohara J
Cell Immunol; 1986 Apr; 99(1):7-13. PubMed ID: 3093104
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules.
Vorderstrasse BA; Kerkvliet NI
Toxicol Appl Pharmacol; 2001 Mar; 171(2):117-25. PubMed ID: 11222087
[TBL] [Abstract][Full Text] [Related]
10. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
11. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD.
Wood SC; Holsapple MP
Toxicol Appl Pharmacol; 1993 Oct; 122(2):308-13. PubMed ID: 8212013
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ig-stimulated B lymphoblasts can be restimulated via their surface Ig.
Isakson PC; D'Angelo D; Schetz J; Tardelli L; Puré E
J Immunol; 1989 Dec; 143(12):3901-8. PubMed ID: 2592762
[TBL] [Abstract][Full Text] [Related]
14. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells.
Dennis G; June CH; Mizuguchi J; Ohara J; Witherspoon K; Finkelman FD; McMillan V; Mond JJ
J Immunol; 1987 Oct; 139(8):2516-23. PubMed ID: 2821117
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced disruption of B-lymphocyte signaling in the mouse: a current perspective.
Karras JG; Holsapple MP
Exp Clin Immunogenet; 1994; 11(2-3):110-8. PubMed ID: 7826659
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking.
Kindler V; Matthes T; Jeannin P; Zubler RH
Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.
Morris DL; Karras JG; Holsapple MP
Immunopharmacology; 1993; 26(2):105-12. PubMed ID: 8282534
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
20. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
